1-1 of 1
Zacharie Mbanya, MSc, MA
Close
Sort by
Journal Articles

Time to Second Objective Disease Progression (PFS2): An Emerging Clinical Trial Endpoint with Regulatory and Reimbursement Implications

Zacharie Mbanya, MSc, MA, Shkun Chadda, MSc.
Journal: Blood
Blood (2014) 124 (21): 6005.
https://doi.org/10.1182/blood.V124.21.6005.6005
Published: 2014